Literature DB >> 19280163

[Cutis verticis gyrata-like acne inversa. Combined medical and surgical management].

P Lehmann1.   

Abstract

A 22-year-old soldier developed during his assignment in Afghanistan purulent draining nodules and fistulas on the scalp. The clinical picture resembled an inflammatory variant of cutis verticis gyrata, and taken together with the histology the diagnosis of acne inversa of the scalp was established. Therapy was started with corticosteroids and isotretinoin, which stopped the secretion of pus: thereafter all there nodules and draining sinuses were excised. After surgery, medication was continued with low dose isotretinoin and dapsone. A complete healing was achieved with this combined regimen.

Entities:  

Mesh:

Year:  2009        PMID: 19280163     DOI: 10.1007/s00105-009-1731-3

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  7 in total

1.  Acne mechanica due to an orthopedic crutch.

Authors:  Y C Kang; E H Choi; S M Hwang; W S Lee; S H Lee; S K Ahn
Journal:  Cutis       Date:  1999-08

2.  Acne mechanica in athletes.

Authors:  R S Basler
Journal:  Cutis       Date:  1992-08

3.  Unusual pyodermas (hidrosadenitis suppurativa, acne conglobata, dissecting cellulitis of the scalp).

Authors:  R R KIERLAND
Journal:  Minn Med       Date:  1951-04

4.  Prevalence of acne keloidalis nuchae in football players.

Authors:  A L Knable; C W Hanke; R Gonin
Journal:  J Am Acad Dermatol       Date:  1997-10       Impact factor: 11.527

5.  [Acne inversa: a dapsone-sensitive dermatosis].

Authors:  T Hofer; P H Itin
Journal:  Hautarzt       Date:  2001-10       Impact factor: 0.751

6.  [Acne inversa (hidradenitis suppurativa): early deetection and curative surgery].

Authors:  A Herrmann; K P Preusser; W C Marsch
Journal:  Chirurg       Date:  2000-11       Impact factor: 0.955

Review 7.  Dapsone and sulfones in dermatology: overview and update.

Authors:  Y I Zhu; M J Stiller
Journal:  J Am Acad Dermatol       Date:  2001-09       Impact factor: 11.527

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.